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Abstract
Objective: Individuals with anorexia nervosa (AN) pursue low-fat, low-calorie diets
even when in a state of emaciation. These maladaptive food choices may involve
fronto-limbic circuitry associated with cognitive control, habit, and reward. We
assessed whether high-frequency repetitive transcranial magnetic stimulation (rTMS)
to the left dorsolateral prefrontal cortex (DLPFC) influenced food-related choice
behavior in patients with severe, enduring (SE)-AN.
Method: Thirty-four females with SE-AN completed a Food Choice Task before and
after 20 sessions of real or sham rTMS treatment and at a 4-month follow-up. During
the task, participants rated high- and low-fat food items for healthiness and tastiness
and then made a series of choices between a neutral-rated food and high- and low-
fat foods. Outcomes included the proportion of high-fat and self-controlled choices
made. A comparison group of 30 healthy women completed the task at baseline only.
Results: Baseline data were consistent with previous findings: relative to healthy controls,
SE-AN participants showed a preference for low-fat foods and exercised self-control on a
greater proportion of trials. There was no significant effect of rTMS treatment nor time on
food choices related to fat content. However, among SE-AN participants who received
real rTMS, there was a decrease in self-controlled food choices at post-treatment, relative
to baseline. Specifically, there was an increase in the selection of tasty-unhealthy foods.
Discussion: In SE-AN, rTMS may promote more flexibility in relation to food choice. This
may result from neuroplastic changes in the DLPFC and/or in associated brain areas.
K E YWORD S
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1 | INTRODUCTION
Anorexia nervosa (AN) is a serious psychiatric disorder involving
food restriction and other weight-control behaviors (e.g., excessive
exercise and self-induced vomiting), body image disturbance, and a
fear of weight gain (American Psychiatric Association, 2013). Treat-
ments are predominantly psychological and/or behavioral therapies
(including nutritional interventions), and are moderately effective
(Brockmeyer, Friederich, & Schmidt, 2018). Repetitive transcranial
magnetic stimulation (rTMS) has been tested as a neuromodulatory
treatment for severe, enduring (SE)-AN (Dalton, Bartholdy, Camp-
bell, & Schmidt, 2018; Dalton, Campbell, & Schmidt, 2017) and may
be a useful tool for altering self-control mechanisms (Figner
et al., 2010).
Maladaptive (excessive) self-control is commonly described in
AN, affecting dietary choices, emotion regulation, and the ability to
delay gratification, among other processes (Fairburn, Shafran, & Coo-
per, 1999; Lavender et al., 2015; Steward et al., 2017). Self-control
refers to a range of competencies (e.g., impulse/inhibitory control,
working memory, and attentional and cognitive flexibility;
Hughes, 2011) employed to initiate, maintain, and control thoughts,
behaviors, or emotions in the enactment of goal-related behavior
(Pandey et al., 2018; Strauman, 2017). It has been proposed that the
maladaptive pursuit of low-fat foods and restriction of food intake in
AN can be considered excessive self-control (Fairburn et al., 1999).
For example, people with AN tend to consume low-fat and low-calorie
diets despite being underweight (Baskaran et al., 2017; Hadigan
et al., 2000; Mayer, Schebendach, Bodell, Shingleton, & Walsh, 2012;
Misra et al., 2006), and this is persistent and contributes to relapse
(Mayer et al., 2012; Schebendach et al., 2019).
The Food Choice Task has been shown to capture the restrictive
food choices characteristic of AN and to identify associated neural
correlates (Foerde, Steinglass, Shohamy, & Walsh, 2015; Steinglass,
Foerde, Kostro, Shohamy, & Walsh, 2015). For example, individuals
with AN have been reported to show greater functional connectivity
between the dorsolateral prefrontal cortex (DLPFC) and the dorsal
striatum for low-fat foods than for high-fat foods, whereas healthy
control (HC) participants showed the opposite (Foerde et al., 2015).
The task has also been used to assess self-control: opportunities for
using self-control arise when food items have incongruent ratings of
healthiness and tastiness, that is, they are tasty and unhealthy, or
non-tasty and healthy. It is assumed that self-control is then
implemented when a healthy, less tasty food item is selected or an
unhealthy, tasty food item is not selected. Individuals with AN have
been reported to exercise self-control on a greater proportion of tri-
als where there is a conflict between healthiness and tastiness rat-
ings, than HCs (Foerde et al., 2015). Specifically, the AN participants
tended to choose the healthier food item, regardless of tastiness.
More broadly, the task has been used to examine neural processes
related to self-control. Hare, Camerer, and Rangel (2009) reported
that healthy individuals, when exercising self-control, showed
increased activity in the DLPFC. Recent research has provided fur-
ther support for the role of the DLPFC in self-control associated
with food choice (Chen, He, Han, Zhang, & Gao, 2018; Lopez,
Courtney, & Wagner, 2019). Given the involvement of the DLPFC in
food choices and reports of its involvement in pathological mecha-
nisms in AN (Compan, Walsh, Kaye, & Geliebter, 2015; Dunlop,
Woodside, & Downar, 2016; Frank, Shott, & DeGuzman, 2019), we
have investigated how modulating neural activity in this area may
influence food choice.
rTMS is a form of non-invasive brain stimulation that uses an
electromagnetic field to alter neuronal activity in a target brain area
(George & Aston-Jones, 2010). High-frequency rTMS (stimulatory;
>10 Hz) to the left DLPFC has been proposed as a promising treat-
ment option for patients with SE-AN (Dalton et al., 2017; Dal-
ton et al., 2018), as it improves eating disorder (ED) and affective
symptoms (McClelland, Kekic, Campbell, & Schmidt, 2016; Van den
Eynde, Guillaume, Broadbent, Campbell, & Schmidt, 2013). Further-
more, qualitative feedback from five patients with SE-AN and their
carers following 20 sessions of rTMS suggested that some patients
felt more able to manage food-related difficulties and had a more
relaxed approach to food choice (e.g., trying new foods) after rTMS
treatment (McClelland et al., 2016).
The main aim of our study therefore was to assess whether 20 ses-
sions of high-frequency rTMS to the left DLPFC altered food choices
(measured using the Food Choice Task) among people with SE-AN. Spe-
cifically, we explored whether rTMS treatment influenced food choices,
measured by the choice of high-fat foods and self-controlled options.
2 | METHODS
We used a UK-based sample of SE-AN and HC participants to investi-
gate/confirm published data on the use of the Food Choice Task in
AN (Foerde et al., 2015; Steinglass et al., 2015). To test the effect of
rTMS on food choice, we used data collected as part of a randomized
controlled feasibility trial investigating multi-session (n = 20) high-fre-
quency rTMS to the left DLPFC as a treatment for SE-AN (Trial regis-
tration: ISRCTN14329415). Methodological details have been
reported in full in Bartholdy, McClelland, et al. (2015; TIARA study
protocol) and Dalton, Bartholdy, McClelland, et al. (2018). The study
received ethical approval from the London—City Road and Hampstead
Research Ethics Committee (Reference: 15/LO/0196) and the King's
College London Psychiatry, Nursing and Midwifery Research Ethics
Subcommittee (Reference: HR-15/16-2836).
2.1 | Participants
Thirty-four community-based women (≥18 years) with SE-AN were
recruited from specialist ED services in London and via online adver-
tisements. Participants were required to have a current Diagnostic
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and Statistical Manual of Mental Disorders (DSM)-5 diagnosis of AN
(American Psychiatric Association, 2013) with a body mass index
(BMI) >14 kg/m2, a minimum illness duration of 3 years and have
completed at least one National Institute for Health and Care Excel-
lence (NICE; 2017)-recommended specialist psychotherapy or special-
ist day-patient or inpatient treatment for their ED. Our definition of
SE-AN is in line with, albeit somewhat less strict than, recent pro-
posals for characterizing SE-AN (Broomfield, Stedal, Touyz, &
Rhodes, 2017; Hay & Touyz, 2018).
HC women (n = 30; ≥18 years), with a BMI in the healthy range
(20–25 kg/m2), were recruited via online and poster advertisements
at King's College London to provide a comparison group. Exclusion
criteria were current/past psychiatric illness or a family history of an
ED. HCs completed the baseline assessment only.
Additional exclusion criteria for all participants related to mag-
netic resonance imaging (MRI) contraindications (e.g., presence of
neurological disease or head trauma) and TMS contraindications (e.
g., epilepsy or seizures) for the participants with SE-AN. Participants
completed a telephone screening to confirm eligibility. This included
the Eating Disorder Diagnostic Scale (Stice, Telch, & Rizvi, 2000) to
assess the presence/absence of ED symptoms in the AN and HC
groups, respectively, and the researcher version of the Structured
Clinical Interview for DSM-IV Axis I Disorders Screening Module
(First, Spitzer, Gibbon, & Williams, 2002) to confirm the absence of
any psychiatric disorders in the HC participants. All participants pro-
vided informed consent.
2.2 | Food Choice Task
Full methodological details of the Food Choice task can be found in
Steinglass et al. (2015). The Food Choice Task has been reported to
have high test–retest reliability (in HCs; Foerde et al., 2018) and has
been validated in patients with AN: caloric intake at lunch significantly
correlated with the frequency with which AN participants chose high-
fat foods in the task (Foerde et al., 2015).
Briefly, the Food Choice Task is comprised of three phases (Fig-
ure 1): the Healthiness Rating phase and Tastiness Rating phase (order
of these blocks were counterbalanced), followed by the Food Choice
phase. Across all three phases of the Food Choice Task, participants
had 4 seconds per trial to provide their response. During each of these
blocks, participants were shown images of the same 76 food items on
a computer screen, chosen to be representative of a range of dietary
choices. Specifically, 38 food items had a low-fat content and 38 were
high-fat (items with >30% of calories derived from fat; Expert Panel
on Detection, Evaluation, and Treatment of High Blood Cholesterol in
Adults, 2001).
In the Healthiness block, participants rated how healthy the food
item was on a 5-point scale from “Unhealthy” to “Healthy” and in
the Tastiness block, participants rated the tastiness of the food item
on a 5-point scale from “Bad” to “Good” (order of rating scales were
counter balanced). Following completion of these phases, one food
item that had been rated as “Neutral” (a score of 3) for both Healthi-
ness and Tastiness was automatically selected as a neutral reference
item to be used in the Choice block. If no item was rated as neutral
on both scales, the reference item was selected from those rated
“Neutral” on the Healthiness scale and “tasty” on the Tastiness scale,
as it would have greater overall value than an unhealthy item for a
participant who made decisions based on health information. This
followed the same algorithm used previously (Foerde et al., 2015;
Steinglass et al., 2015).
In the Choice block, participants indicated their strength of prefer-
ence for the trial-unique food item, as compared with the neutral-
rated reference item. The reference item did not change throughout
the Choice block and was visible throughout on the left side of the
screen. A rating of 1 or 2 indicated selection of the reference item and
a rating of 4 or 5 indicated selection of the trial-unique food item. Par-
ticipants were instructed to imagine that they would receive a snack-
sized portion of one of their selections at the end of the study.
The main outcome on the task was the proportion of high-fat trial-
unique food items chosen over the reference item. The secondary out-
come was the proportion of self-controlled choices that were made (i.e.,
choosing healthy, less tasty foods or not choosing unhealthy, tasty foods).
2.3 | Additional measures
The Eating Disorder Examination-Questionnaire (EDE-Q) (Fairburn &
Beglin, 2008) assessed ED symptoms and behaviors over the previous
28 days. The Depression Anxiety and Stress Scales—Version 21
F IGURE 1 Examples of the three blocks of the Food Choice Task [Color figure can be viewed at wileyonlinelibrary.com]
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(DASS-21; Lovibond & Lovibond, 1995) measured general psychopa-
thology, including depression, anxiety, and stress, over the previous
7 days. Data from other questionnaires administered are reported in
Dalton, Bartholdy, McClelland, et al. (2018).
2.4 | Procedure
2.4.1 | Baseline assessment
Both SE-AN and HC participants attended a research session at the
Institute of Psychiatry, Psychology & Neuroscience, King's College
London. Pa`rticipants' height and weight were measured. Following
an MRI scan, participants completed the Food Choice Task, along with
additional computer tasks and a battery of questionnaires.
2.4.2 | rTMS trial
Following the baseline assessment, the SE-AN participants were ran-
domly allocated to receive 20 sessions (over 4 weeks) of real (n = 17)
or sham (n = 17) neuro-navigated rTMS in addition to treatment-as-
usual (e.g., specialist ED outpatient or day-patient treatment, or no
current treatment). The Magstim Rapid device and Magstim D70-mm
air-cooled real and sham coils were used to administer rTMS. Partici-
pants in the real group received 20 sessions of high-frequency (10 Hz)
rTMS at 110% of their individual motor threshold, consisting of
twenty 5-second trains with 55-second inter-train intervals delivered
to the left DLPFC (a total of 1,000 pulses delivered over each 20-
minute session). Sham stimulation was administered at the same
parameters using a sham coil.
Participants repeated the baseline assessment within 1 week of
completing rTMS treatment (post-treatment; 1-month post-randomiza-
tion) and at a follow-up (4-months post-randomization; without the neu-
roimaging component) prior to unblinding (n = 30: n = 16 real rTMS,
n = 14 sham rTMS).
2.5 | Statistical analysis
Demographic characteristics were compared between diagnostic
groups (HC vs. SE-AN) and rTMS treatment groups (real vs. sham
rTMS at each assessment time point: baseline, post-treatment, and
follow-up) using unpaired t tests. Tests were two-tailed unless oth-
erwise specified. If unequal variances were indicated, degrees of
freedom were adjusted accordingly. Between-group effect sizes
(Cohen's d with 95% confidence intervals) for clinical outcomes at
post-treatment and follow-up (adjusted for baseline) were
calculated.
Food Choice Task data were analyzed using multilevel regression
models (lme4 linear mixed effects package for R; Bates, Maechler, &
Bolker, 2012) in order to account for random effects, unbalanced data,
and to minimize the influence of outliers. In all analyses, models
included by-subject random intercepts and slopes (Barr, 2013).
Continuous outcome rating data from the Healthiness and Tasti-
ness phases were modeled using multilevel linear regression. When
entered as independent variables, continuous rating data were z-
scored. The significance of the partial correlation coefficients was
assessed by χ2 statistics and accompanying p values derived for the
estimates from Type-III analysis of variance tables from the ANOVA
function in the car package for R (Fox et al., 2012).
For Choice phase data, choices on the five-point scale were
converted to binary “Yes” or “No” preferences for the trial-unique
food item versus the reference item: responses of 1 or 2 on the Likert
scale were converted to “No” (0) and responses of 4 or 5 were
converted to “Yes” (1); neutral responses of 3 were omitted from ana-
lyses. Binomial choice data were modeled with multilevel logistic
regression, in which participant choice (selection of the trial-unique
food item over the reference food) was the dependent variable.
For analyses of “self-control” in the Choice phase, trials were first
categorized as to whether they presented an opportunity for self-con-
trol or not, and the proportion of such trials was calculated. Self-con-
trol opportunities arose on trials with incongruent Healthiness and
Tastiness ratings (see Figure 3A): food items rated tasty and unhealthy
or non-tasty and healthy. On such trials, self-control was assumed to
be implemented if a tasty and unhealthy item was not chosen (i.e., the
TABLE 1 Demographic and clinical characteristics for the healthy control and anorexia nervosa participants at the baseline assessment
Healthy controls (n = 29) Anorexia nervosa (n = 30) Group comparison
Age (years) (median [IQR]) 25.00 (5.00) 27.00 (11.50) U = 331, p = .115
Illness duration (years) (mean ± SD) 15.70 ± 11.60
AN-R/AN-BP (n) 21/9
BMI (kg/m2) (mean ± SD) 21.80 ± 1.50 15.90 ± 1.40 t(56) = 15.2, p < .001
EDE-Q Global (median [IQR]) 0.27 (0.56) 4.28 (1.53) U = 1, p < .001
DASS-21 Depression (median [IQR]) 2.00 (2.00) 28.00 (16.00) U = 9.5, p < .001
DASS-21 Anxiety (median [IQR]) 2.00 (2.00) 14.00 (16.00) U = 60, p < .001
Note: BMI, EDE-Q, and DASS-21 data were missing from one participant with AN.
Abbreviations: AN-BP, anorexia nervosa binge-eating/purging type; AN-R, anorexia nervosa restricting type; BMI, body mass index; DASS-21, Depression
Anxiety and Stress Scales—Version 21; EDE-Q, Eating Disorder Examination Questionnaire; IQR, interquartile range; SD, standard deviation.
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F IGURE 2 Food Choice Task behavior in individuals with anorexia nervosa and healthy control participants in the baseline research
assessment. (A) Health ratings were significantly higher for low-fat foods than high-fat foods, and the anorexia nervosa group-rated foods as less
healthy overall. (B) The anorexia nervosa group rated high-fat foods in particular as less tasty than did the healthy control group. (C) In the Choice
phase, the anorexia nervosa group was less likely than the healthy control group to choose high-fat foods in particular. See text for description of
statistically significant effects. AN, anorexia nervosa; HC, healthy control
F IGURE 3 Food choices and self-control. (A) Schematic of how food ratings are used to determine trials that present opportunities to
implement self-controlled choices versus trials that do not present self-control conflict. (B) The healthy control and anorexia nervosa groups had a
similar proportion of trials on which self-control conflict could arise. (C) On trials presenting opportunity for self-control, the anorexia nervosa
group was more likely to make self-controlled choices. (D) Self-control opportunities occurred on two different types of trials: when food items
were rated as tasty and unhealthy or not tasty and healthy. The anorexia nervosa group made more self-controlled choices on both types of trials.
*Indicates p < .05. AN, anorexia nervosa; HC, healthy control [Color figure can be viewed at wileyonlinelibrary.com]
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reference item was chosen) or if a non-tasty healthy item was chosen.
Self-control opportunity and implementation and choices on different
self-control trial types were modeled with multilevel logistic
regression.
Pearson correlation was used to assess the relationship
between mean Tastiness ratings, proportion of high-fat food choices,
or self-control use on the Food Choice Task at baseline with clinical
parameters (e.g., duration of illness and EDE-Q Global score) in the
SE-AN group.
3 | RESULTS
3.1 | Cross-sectional comparison of baseline
assessment
At baseline, data were lost from four SE-AN participants and one HC
due to computer error. Therefore, 30 participants with SE-AN and 29
HCs completed the task at the baseline assessment. Demographics
and clinical characteristics for both groups are shown in Table 1. The
groups did not differ in age (p = .115), but as expected, SE-AN partici-
pants had lower BMI and higher EDE-Q Global scores than
HCs (p < .001).
TABLE 2 Demographic and clinical characteristics for anorexia nervosa participants in each arm of the rTMS trial at the baseline,
post-treatment, and follow-up assessments, with the estimated between-group effect sizes (Cohen's d with 95% confidence intervals) for
post-treatment and follow-up clinical characteristics (adjusted for baseline*)
Real rTMS (n = 13) Sham rTMS (n = 13) t df p d (95% CI)
Age (years) (mean ± SD) 30.20 ± 10.00 31.30 ± 12.50 −0.24 24 .81
Illness duration (years) (mean ± SD) 15.96 ± 11.40 15.40 ± 12.20 0.13 24 .90
AN-R/AN-BP (n) 9/4 9/4
Treatment at baseline (n)a
ED day-patient treatment 0 1
ED outpatient treatment 10 9
No treatment 3 4
Antidepressant medicationb 8 7
Other psychotropic medicationb,c 2 4
BMI (kg/m2) (mean ± SD)
Baseline 15.70 ± 1.40 16.30 ± 1.20 −0.97 24 .34
Post-treatment 15.60 ± 1.30 16.20 ± 1.30 −1.10 24 .30 −0.16 (−0.93 to 0.61)
Follow-up 15.70 ± 1.70 16.10 ± 1.60 −0.70 24 .51 0.08 (−0.69 to 0.84)
EDE-Q Global (mean ± SD)
Baseline 4.00 ± 1.30 4.20 ± 0.80 −0.47 24 .64
Post-treatment 3.70 ± 1.20 3.80 ± 1.30 −0.05 24 .96 0.21 (−0.56 to 0.98)
Follow-up 3.60 ± 1.40 3.60 ± 1.30 −0.03 24 .98 0.20 (−0.57 to 0.97)
DASS-21 Depression (mean ± SD)
Baseline 27.10 ± 9.50 24.60 ± 9.98 0.65 24 .53
Post-treatment 22.00 ± 10.80 21.50 ± 9.10 0.10 24 .92 −0.20 (−0.97 to 0.58)
Follow-up 17.20 ± 10.20 22.90 ± 13.20 −1.10 24 .23 −0.81 (−1.61 to −0.004)
DASS-21 Anxiety (mean ± SD)
Baseline 16.60 ± 8.50 14.60 ± 12.60 0.47 24 .64
Post-treatment 9.10 ± 10.30 10.50 ± 9.10 −0.36 24 .72 −0.55 (−1.33 to 0.24)
Follow-up 10.90 ± 9.40 13.50 ± 12.30 −0.61 24 .55 −0.69 (−1.48 to 0.11)
*Post-treatment/follow-up scores minus baseline scores. Bold font signifies that the CI do not include 0.
Abbreviations: AN-BP, anorexia nervosa binge-eating/purging type; AN-R, anorexia nervosa restricting type; BMI, body mass index; CI, confidence interval;
df, degrees of freedom; DASS-21, Depression Anxiety and Stress Scales—Version 21; ED, eating disorder; EDE-Q, Eating Disorder Examination Question-
naire; SD, standard deviation.
aReported at screening/baseline assessment.
bMedication remained at a stable dose for the duration of rTMS treatment.
cIncluding antipsychotics, benzodiazepine/other anxiolytic/sedative medication.
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3.1.1 | Healthiness and Tastiness ratings
Figure 2 shows the average Healthiness (A) and Tastiness (B) ratings
for low- and high-fat foods for the SE-AN and HC groups. Both
groups rated high-fat foods as less healthy than low-fat foods
(χ2 = 1,176.83, p < .001). Additionally, the SE-AN group rated food
items as less healthy overall (χ2 = 5.07, p = .024). There was no inter-
action between Group and Food Type (high-fat vs. low-fat) on Health-
iness ratings (χ2 = 2.95, p = .086).
For the Tastiness ratings, there was no main effect of Food Type
(χ2 = 3.22, p = .073). There was a main effect of Group (χ2 = 6.27,
p = .012) and a significant Group × Food Type interaction (χ2 = 4.04,
p = .044), indicating that the SE-AN group rated high-fat foods in particu-
lar as less tasty than did the HC group.
3.1.2 | Food choices by fat content
Figure 2C shows choice proportions for low- and high-fat foods for the
SE-AN and HC groups. There was a significant main effect of Food Type
(z = −4.39, p < .001), such that high-fat foods were less likely to be cho-
sen relative to low-fat foods. There was a trend toward a main effect of
Group (z = −1.94, p = .0525). We found a significant Group × Food type
interaction (z = −5.39, p < .001), demonstrating that the SE-AN group
were less likely to choose high-fat foods relative to HC participants.
3.1.3 | Food choices and self-control
There was no significant group difference in the number of trials with
an opportunity for self-control (proportion of trials with conflict
between Healthiness and Tastiness ratings; z = −1.14, p = .26; Fig-
ure 3B). On trials that presented opportunities to make a self-con-
trolled choice, the SE-AN group were more likely to use self-control
than the HCs (z = 5.55, p < .001; Figure 2C).
When self-control use trials were considered separately (Not-
Tasty Healthy choice vs. Tasty-Unhealthy choice), there was a main
effect of Group for both trial types, such that SE-AN participants
chose healthy, less tasty foods more (z = 3.49, p < .001) and
unhealthy, tasty foods less (z = −4.76, p < .001), compared to HCs
(Figure 3D).
3.1.4 | Associations between food choice and
clinical parameters
Among individuals with SE-AN, there was a significant inverse correlation
between mean Tastiness rating and illness duration (r = −.47, p = .008).
Illness duration and age are generally tightly related, as they were in this
group of participants (r = .91), and the correlation between illness dura-
tion and Tastiness rating did not remain significant when age was
included. However, Tastiness rating and age were not correlated in the
HC group (r = −.11, p = .58). In the SE-AN participants, high-fat food
choice proportion was not significantly correlated with illness duration
(r = −.31, p = .095) nor EDE-Q Global Score (r = −.18, p = .33). No clinical
parameters were associated with self-control use (p > .05).
3.2 | Effect of rTMS on food choice
Data were available for 26 (out of 30) participants who completed the
trial: 13 participants who received real rTMS (n = 13 at baseline, n = 12
at post-treatment, n = 13 at follow-up) and 13 participants who received
sham rTMS (n = 13 at baseline, n = 13 at post-treatment, n = 12 at fol-
low-up). Groups did not significantly differ in baseline demographics nor
in clinical characteristics (BMI, ED symptoms, depression and anxiety
symptoms) at baseline, post-treatment, or follow-up assessments
(Table 2). Between-group effect sizes were small for BMI and ED symp-
toms and moderate for anxiety symptoms at both post-treatment and
follow-up (adjusted for baseline), favoring real rTMS treatment (except
for BMI at post-treatment; see Table 2). Group differences for depres-
sion were of small effect at post-treatment, but of large effect (d = −.81,
see Table 2) at follow-up, favoring real rTMS.
3.2.1 | Healthiness and Tastiness ratings
There was no significant effect of Time or rTMS Treatment Type on
Healthiness or Tastiness ratings.
3.2.2 | Food choices by fat content
Similarly, there were no significant changes in food choices by fat con-
tent over time or with rTMS treatment. However, there appeared to
F IGURE 4 Effect of repetitive transcranial magnetic stimulation
on self-control (as described in Figure 3A): the percentage of trials on
which self-control was used, out of trials on which there was a
conflict between Healthiness and Tastiness ratings, across sham and
real rTMS groups at baseline and post-treatment. Plotted are group
averages with 95% confidence intervals. rTMS, repetitive transcranial
magnetic stimulation
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be a trend toward an interaction between Treatment and Time for
baseline versus post-treatment (z = 1.65, p = .099), such that there
was a general shift in choices for both high- and low-fat foods.
3.2.3 | Food choices and self-control
Opportunities for use of self-control did not differ between sham and real
rTMS groups or between time points. Comparing sham and real rTMS
groups at post-treatment versus baseline, a significant effect of Treatment
(z = 2.42, p = .016) was qualified by a significant interaction between
Treatment and Time on the use of self-control (z = 2.24, p = .025), such
that participants who received real rTMS had decreased self-control use
at post-treatment, relative to baseline (Figure 4). At follow-up, an effect
of Treatment was observed (z = 2.17, p = .030) that did not interact with
Time (z = 0.25, p = .80).
When we examined the self-control trial types separately (Not-
Tasty Healthy choice and Tasty-Unhealthy choice; see Figure 3A),
there was no Treatment or Time main effects or interaction with
respect to the Not-Tasty Healthy choice. However, we did find a
Treatment main effect for the Tasty-Unhealthy choice (z = −2.07,
p = .038) and a significant interaction between Time and Treatment
(z = −2.62, p = .009), such that there was an increased selection of
Tasty-Unhealthy foods in participants who received real rTMS at
post-treatment (relative to baseline).
4 | DISCUSSION
In this study, we assessed the effects of 20 sessions of real or sham
high-frequency (excitatory) rTMS treatment to the left DLPFC on out-
comes of the Food Choice Task in people with SE-AN. As part of this,
we investigated the use of the Food Choice Task in a UK-based sam-
ple to compare our data with published work (Foerde et al., 2015;
Steinglass et al., 2015). Our baseline data were consistent with previ-
ous research: relative to HCs, SE-AN participants (a) rated food items
as less healthy; (b) rated food items, high-fat foods in particular, as less
tasty; (c) showed a preference for low-fat foods and made fewer
choices of high-fat foods; and (d) exercised self-control on a greater
proportion of trials (i.e., they selected Not-Tasty Healthy foods more
and Tasty Unhealthy foods less). This pattern of food choice is in
accord with the broader literature on dietary patterns in AN (Allen
et al., 2013; Baskaran et al., 2017; Mayer et al., 2012).
rTMS treatment did not affect ratings associated with healthiness
or tastiness, nor food choices by fat content in patients with SE-AN.
Although not significant (p = .099), there was a general shift in choices
away from the neutral reference food toward the trial-unique food
items (both high- and low-fat) in the real rTMS group. This may reflect
the development of a more flexible attitude toward food. Real rTMS
(compared to sham rTMS) was also associated with significantly fewer
self-controlled food choices at post-treatment, relative to baseline.
This finding may have been driven by the increased choice of “Tasty-
Unhealthy” foods, as the selection of “Not-Tasty Healthy” foods did
not change. A previous case series in SE-AN reported that the thera-
peutic effects of rTMS treatment on psychopathology (improvements
in ED and affective symptoms) persisted at a 6-month follow-up
(McClelland et al., 2016). Therefore, a reduction in self-controlled
choices in the Food Choice Task at follow-up may have been
expected. It is unclear why, in the present study, we did not observe a
maintained effect on food choice at follow-up. It may be due to vari-
ability in the nature of support and treatment experiences of partici-
pants in the follow-up phase, for example, reducing or minimal/absent
therapeutic support, against a background of severe and enduring ill-
ness. It is possible that combining rTMS with a form of psychological
therapy or behavioral intervention might help translate the reduced
self-controlled food choices into real-life long-term changes in food
intake.
As the DLPFC is involved in cognitive control (Ridderinkhof, van
den Wildenberg, Segalowitz, & Carter, 2004) and AN is often charac-
terized as a disorder of excessive self-control (Fairburn et al., 1999), it
is perhaps counterintuitive that modulating this area with high-fre-
quency (i.e., excitatory) rTMS appears to promote a more flexible
approach to food choice i.e., a reduction in self-controlled choices.
High-frequency rTMS to the DLPFC may have increased the cognitive
control needed to override maladaptive restrictive food choices. Some
possible mechanisms are discussed in the following.
Habit and reward are associated with fronto-striatal circuitry and
have been implicated in the pathogenesis of AN (O'Hara et al., 2016),
and more specifically, restrictive food intake (Compan et al., 2015;
O'Hara, Campbell, & Schmidt, 2015; Steinglass & Walsh, 2016). For
example, restrictive food intake may occur in AN because secondary
(contextual) rewards, such as dietary restriction, are more rewarding
than primary (immediate) rewards, such as food (Keating, 2010; Keat-
ing, Tilbrook, Rossell, Enticott, & Fitzgerald, 2012). It is also possible
that, over time, restrictive food intake in AN may become a habit
(Godier & Park, 2014; O'Hara et al., 2016; Steinglass & Walsh, 2016;
Walsh, 2013). Thus, rTMS may increase the cognitive control needed
to (a) choose rewards that carry low value but are in line with the goal
of recovery or (b) disrupt maladaptive habitual behaviors. Both can be
reflected in the increased proportion in choices of tastier but less
healthy foods. These changes may occur via rTMS effects on neuro-
plasticity in the DLPFC and related neurocircuits (Cheeran, Koch,
Stagg, Baig, & Teo, 2010; Houdayer et al., 2008; Zhao, Li, Tian, Zhu, &
Zhao, 2019), such as those implicated in models of AN which propose
etiological roles for habit and reward (Compan et al., 2015; Dunlop
et al., 2016; Frank et al., 2019). For example, excitatory rTMS may
alter the efficiency of the regulatory effect of the DLPFC on tonic
amygdala activity, a brain region that has been associated with anxiety
and the wider negative valence system (Dunlop et al., 2016).
It is also important to consider that changes in mood might be rel-
evant to the mechanism of action of rTMS in SE-AN, as, for example,
it has been proposed that in AN, dietary restriction may be used to
modulate/regulate mood (Haynos & Fruzzetti, 2011). On this basis, it
would be expected that rTMS-related improvements in mood would
reduce the need to restrict food intake and make self-controlled
choices on the Food Choice Task. However, we did not see
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significantly greater improvements in mood in the real rTMS group,
compared to the sham group, at post-treatment, that is, these were
not evident until the follow-up (4-months post-randomization; see
Table 2 and Dalton, Bartholdy, McClelland, et al., 2018). The observed
reduction in self-controlled food choices associated with real rTMS
was also not reflected in other measures used to assess participants'
rTMS treatment response (as reported in Dalton, Bartholdy,
McClelland, et al., 2018). For example, the real and sham rTMS groups
did not significantly differ in weight gain, ED symptoms, anxiety, nor
food-related anxiety (measured by the Fear of Food Measure,
Levinson & Byrne, 2015; see Dalton, Bartholdy, McClelland, et al., 2018)
at post-treatment and follow-up assessments. Given that there was not a
significantly greater improvement in these clinical characteristics in the
real rTMS group compared to the sham rTMS group at the post-treat-
ment assessment, the observed reduction in self-control use in the real
rTMS group is likely not attributable to clinical improvements.
4.1 | Strengths and limitations
This is the first study to systematically assess food choice before and
after multiple sessions of rTMS treatment in patients with SE-AN. We
used a validated Food Choice Task that allows for choices to be cali-
brated to individualized food preferences. The findings shed some light
on potential mechanisms of action of rTMS in SE-AN. The AN sample
was small and heterogenous, particularly in relation to illness duration.
With increased illness duration, maladaptive behaviors may become
entrenched and hence, may influence responsivity to rTMS. Also, the
sample was not ethnically diverse and did not include men. Psychiatric
comorbidities in the SE-AN patients were not assessed using expert-
rated diagnostic interviews; however, related symptoms were measured
using self-report questionnaires. Task administration was not standard-
ized in relation to mealtimes and a few US food items were unknown to
participants. The follow-up period may have been too short to identify
improvements in food choice, particularly given the enduring nature of
illness in our sample. However, research of real-world food intake behav-
ior suggests that maladaptive food choices (e.g., a reduced percent of cal-
ories from fat compared to HCs) persist throughout recovery from AN
(Mayer et al., 2012). Finally, we did not assess whether rTMS led to
changes in everyday food intake. Despite this, our findings suggest a pos-
sible mechanism by which rTMS in SE-AN may influence illness-related
behaviors, such as restrictive food intake.
5 | CONCLUSION
We assessed food choice as an outcome following 20 sessions of real
or sham high-frequency rTMS treatment to the left DLPFC in patients
with SE-AN. In parallel, we confirmed the results of previous Food
Choice Task studies in a UK-based sample of people with SE-AN. rTMS
did not alter ratings of Healthiness and Tastiness nor did it change food
choices by fat content. However, real rTMS may have contributed to
reduced self-control use in the Food Choice Task at post-treatment
(relative to baseline). This may be associated with neuroplastic changes
in the DLPFC and associated neurocircuits. This study contributes to
the emerging evidence for rTMS as a treatment for AN and to the
growing literature investigating how rTMS exerts its effects.
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